Lorenzo Gervaso

746 total citations
46 papers, 447 citations indexed

About

Lorenzo Gervaso is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Lorenzo Gervaso has authored 46 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Epidemiology. Recurrent topics in Lorenzo Gervaso's work include Neuroendocrine Tumor Research Advances (13 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Lung Cancer Research Studies (9 papers). Lorenzo Gervaso is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Lung Cancer Research Studies (9 papers). Lorenzo Gervaso collaborates with scholars based in Italy, United States and Germany. Lorenzo Gervaso's co-authors include Alok A. Khorana, Alberto J. Montero, Xuefei Jia, Nicola Fazio, Keith R. McCrae, Ann S. Kim, Bicky Thapa, Pauline Funchain, Chiara Alessandra Cella and C.A. Reddy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lorenzo Gervaso

39 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenzo Gervaso Italy 10 208 202 144 110 57 46 447
M. Sinn Germany 9 291 1.4× 142 0.7× 103 0.7× 102 0.9× 106 1.9× 19 517
Sudha Parasuraman United States 8 102 0.5× 83 0.4× 53 0.4× 75 0.7× 53 0.9× 15 304
J.L. Balibrea Spain 12 150 0.7× 201 1.0× 143 1.0× 106 1.0× 138 2.4× 18 562
Feras Abu Saadeh Ireland 11 73 0.4× 178 0.9× 100 0.7× 46 0.4× 65 1.1× 41 483
D. Anthony Barcel United States 4 78 0.4× 211 1.0× 68 0.5× 41 0.4× 115 2.0× 8 472
Milena Todorović Serbia 12 173 0.8× 63 0.3× 27 0.2× 51 0.5× 54 0.9× 76 514
Anders Christian Larsen Denmark 12 176 0.8× 76 0.4× 56 0.4× 100 0.9× 122 2.1× 28 405
Jwa Hoon Kim South Korea 11 182 0.9× 30 0.1× 25 0.2× 112 1.0× 81 1.4× 30 348
H. Lacroix Belgium 13 273 1.3× 112 0.6× 112 0.8× 460 4.2× 236 4.1× 39 726
Xiaoli Zhu China 13 77 0.4× 38 0.2× 18 0.1× 125 1.1× 99 1.7× 39 459

Countries citing papers authored by Lorenzo Gervaso

Since Specialization
Citations

This map shows the geographic impact of Lorenzo Gervaso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Gervaso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Gervaso more than expected).

Fields of papers citing papers by Lorenzo Gervaso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Gervaso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Gervaso. The network helps show where Lorenzo Gervaso may publish in the future.

Co-authorship network of co-authors of Lorenzo Gervaso

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Gervaso. A scholar is included among the top collaborators of Lorenzo Gervaso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Gervaso. Lorenzo Gervaso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Massironi, Sara, Lorenzo Gervaso, Paoletta Preatoni, et al.. (2025). Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes. Cancers. 17(2). 212–212.
3.
Cella, Chiara Alessandra, Davide Ciardiello, Lorenzo Gervaso, et al.. (2024). Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape. SHILAP Revista de lepidopterología. 4. 100048–100048. 3 indexed citations
4.
Cella, Chiara Alessandra, Benjamin Djulbegović, Iztok Hozo, et al.. (2024). Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer. European Journal of Cancer. 209. 114234–114234.
5.
Gervaso, Lorenzo, Aurora Gaeta, Sara Gandini, et al.. (2024). Venous thromboembolism in pancreatic neuroendocrine neoplasm: a cohort study. Research and Practice in Thrombosis and Haemostasis. 8(3). 102381–102381. 1 indexed citations
6.
Quaquarini, Erica, Federica Grillo, Lorenzo Gervaso, et al.. (2024). Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas. Cancers. 16(18). 3145–3145. 2 indexed citations
7.
Gervaso, Lorenzo, Gianmaria Frigè, Francesca Spada, et al.. (2024). The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers. 16(19). 3349–3349. 2 indexed citations
8.
Ciardiello, Davide, Lorenzo Gervaso, Lorella Marinucci, et al.. (2024). Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer. Journal of Molecular Diagnostics. 27(2). 130–138.
9.
Valenza, Carmine, Dario Trapani, Edoardo Crimini, et al.. (2024). Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study. ESMO Open. 9(8). 103662–103662.
10.
Calvello, Mariarosaria, Monica Marabelli, Sara Gandini, et al.. (2023). Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience. Genes. 14(5). 1077–1077. 5 indexed citations
11.
Luc, M., Stefano De Pascale, Alessandro Bonomi, et al.. (2023). Textbook outcome as indicator of surgical quality in a single Western center: results from 300 consecutive gastrectomies. Updates in Surgery. 76(4). 1357–1364. 4 indexed citations
12.
Gervaso, Lorenzo, Luca Bottiglieri, Roberto Biffi, et al.. (2023). Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy. Clinical & Translational Oncology. 25(11). 3287–3295. 1 indexed citations
13.
Gervaso, Lorenzo, et al.. (2023). Efficacy and safety of systemic chemotherapy for radically resectable esophago-gastric adenocarcinoma in older patients: A systematic review and meta-analysis. Journal of Geriatric Oncology. 15(1). 101600–101600. 2 indexed citations
14.
Spada, Francesca, Samuele Frassoni, Vincenzo Bagnardi, et al.. (2022). Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis. Journal of Neuroendocrinology. 34(10). e13189–e13189. 1 indexed citations
15.
Gervaso, Lorenzo, et al.. (2022). Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis. Cancer Treatment Reviews. 104. 102338–102338. 7 indexed citations
16.
Swaidani, Shadi, Ann S. Kim, Bicky Thapa, et al.. (2021). Increased incidence of venous thromboembolism with cancer immunotherapy. Med. 2(4). 423–434.e3. 84 indexed citations
17.
Gervaso, Lorenzo, et al.. (2021). Venous and Arterial Thromboembolism in Patients With Cancer. JACC CardioOncology. 3(2). 173–190. 89 indexed citations
18.
Gervaso, Lorenzo, Florian Lordick, & Nicola Fazio. (2021). Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma—Is It Based on Evidence or Clinical Wisdom?. JAMA Oncology. 7(12). 1759–1759. 7 indexed citations
19.
Aliaga, Pamela Trillo, Francesca Spada, Giulia Peveri, et al.. (2021). Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis. Cancer Treatment Reviews. 99. 102261–102261. 11 indexed citations
20.
Tancredi, Richard, et al.. (2017). End-of-life chemotherapy and adherence to ASCO’s Top Five List recommendations: A single-center retrospective review.. Journal of Clinical Oncology. 35(15_suppl). e21509–e21509. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Sinn Breakdown of academic impact, for papers by Sudha Parasuraman Breakdown of academic impact, for papers by J.L. Balibrea Breakdown of academic impact, for papers by Feras Abu Saadeh Breakdown of academic impact, for papers by D. Anthony Barcel Breakdown of academic impact, for papers by Milena Todorović Breakdown of academic impact, for papers by Anders Christian Larsen Breakdown of academic impact, for papers by Jwa Hoon Kim Breakdown of academic impact, for papers by H. Lacroix Breakdown of academic impact, for papers by Xiaoli Zhu
Rankless by CCL
2026